Coya Therapeutics Q3 EPS $(0.45) Misses $(0.34) Estimate, Sales $234.134K Beat $85.714K Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.34) by 32.35 percent. This is a 246.15 percent decrease over losses of $(0.13) per share
Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.34) by 32.35 percent. This is a 246.15 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $234.134 thousand which beat the analyst consensus estimate of $85.714 thousand by 173.16 percent. This is a 93.43 percent decrease over sales of $3.564 million the same period last year.